Skip to main content

Table 1 Demographic, clinical, and serological features, according to ESSG index[8],[9]

From: Nailfold videocapillaroscopy micro-haemorrhage and giant capillary counting as an accurate approach for a steady state definition of disease activity in systemic sclerosis

  Whole cohort Patients with lcSSc Patients with dcSSc
Patients (F/M) 107 (97 F, 10 M) 57 (53 F, 4 M) 50 (44 F, 6 M)
Mean age (range) (yrs.)1 55.8 (18-84) 58.1 (28-84) 53.3 (18-84)
Mean disease duration (range) (yrs.) 6.1 (0.5-30) 7.4 (0.5-30) 4.8 (0.5-20)
ESSG index ≥3.5 (no. of pts.)2 (%) 32 (29.9%) 18 (16.8%) 14 (13.1%)
Mean mRSS (range) (yrs.) 3.1 (0-32) 2.4 (0-5) 3.5 (0-32)
Scleredema (no. of pts.) (%) 60 (56.1%) 32 (56.1%) 28 (56.0%)
Δ3Skin involvement (no. of pts.) (%) 18 (16.8%) 11 (19.2%) 7 (14.0%)
Ulcers (no. of pts.) (%) 22 (21.5%) 11 (19.2%) 11 (22.0%)
Δ1Vascular features (no. of pts.) (%) 25 (23.4%) 14 (24.5%) 11 (22%)
Arthritis (no. of pts.) (%) 5 (4.7%) 3 (5.2%) 2 (4%)
DLCO <80%4 (no. of pts.) (%) 67 (63.2%) 35 (61.4%) 32 (64.0%)
Δ1Cardiopulmonary features (no. of pts.) (%) 20 (18.7%) 10 (17.5%) 10 (20.0%)
ESR >30 mm/h (no. of pts.) (%) 32 (29.9%) 14 (24.5%) 18 (36.0%)
Hypocomplementemia (no. of pts.) (%) 12 (11.7%) 9 (15.7%) 3 (6.0%)
  1. 1Yrs. = years; 2pts = patients; 3worsening in the specific organ/system involvement; 4a diffusing lung capacity for carbon monoxide below 80% of predicted value. ESSG, European Scleroderma Study Group; lcSSc, limited cutaneous systemic sclerosis; dcSSc, diffuse cutaneous systemic sclerosis; mRSS, modified Rodnan skin score; DLCO, diffusing capacity; ESR, erythrocyte sedimentation rate.